Get timely information about the opioid epidemic in Oregon and elsewhere.

Featured Story

FDA Approves Indivior’s Monthly Injection to Treat Opioid Addiction
STAT News reports that the FDA has approved a new form of a the widely used treatment medication buprenorphine. The new form, Sublocade, is injected monthly instead of taken daily as a tablet. Experts say the new version of the drug may help patients reduce relapses, may disrupt the treatment market, and possibly address concerns about buprenorphine’s potential for abuse. A similar injectible buprenophine product made by Braeburn is expected to be approved by FDA early next year. (Nov. 30, 2017)

Oregon News

National News

News Features